Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new ...

Investors are eager for the Benchling IPO. The company made headlines when it confidentially filed with the SEC to go public. Biotechnology is rewriting life as we know it. Our customers, spanning ...

SAN FRANCISCO and BOSTON, May 7, 2025 /PRNewswire/ -- Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna. What began with Benchling ...

Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a software framework that helps bring Merck's pre-clinical and clinical ...

Antibody R&D teams can configure any format in minutes and register up to 1,000 antibodies in a single run Benchling Biologics is the end-to-end platform for antibody R&D, giving teams the AI-ready ...

Antibody R&D teams can configure any format in minutes and register up to 1,000 antibodies in a single run "Most R&D systems can't represent the antibody formats teams are actually working with," said ...